Non-profits accelerate development of a vaccine for the Bundibugyo Ebola strain in DRC and Uganda The rVSV single-dose vaccine candidate is seen as the most promising by WHO experts CEPI funds three vaccine candidates, including rVSV, Oxford’s ChAdOx1, and Moderna’s mRNA jab